165 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
Top Research Reports for Walmart, AT&T & Novo Nordisk http://www.zacks.com/research-daily/162868/top-research-reports-for-walmart-att-novo-nordisk?cid=CS-ZC-FT-162868 May 18, 2018 - Top Research Reports for Walmart, AT&T & Novo Nordisk
Novo Nordisk Fights Payer Pressure With New Meds https://www.fool.com/investing/2018/05/07/novo-nordisk-fights-payer-pressure-with-new-meds.aspx?source=iedfolrf0000001 May 07, 2018 - Sales of older medications are on the decline, but newer medications helped the revenue line grow at constant exchange rates.
Novo Nordisk (NVO) Q1 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/05/03/novo-nordisk-nvo-q1-2018-earnings-conference-call.aspx?source=iedfolrf0000001 May 03, 2018 - NVO earnings call for the period ending March 31, 2018.
Novo Nordisk A/S (NVO) Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4168612-novo-nordisk-s-nvo-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 02, 2018 - Novo Nordisk A/S (NYSE:NVO)Q1 2018 Earnings CallMay 02, 2018 7:00 am ETExecutivesLars Fruergaard Jørgensen - Novo Nordisk A/SMads Krogsgaard Thomsen - Novo Nordisk A/SKarsten Munk Knudsen - Novo Nordi
Novo Nordisk (NVO) Beats Q1 Earnings Estimates, Sales Miss http://www.zacks.com/stock/news/301962/novo-nordisk-nvo-beats-q1-earnings-estimates-sales-miss?cid=CS-ZC-FT-301962 May 02, 2018 - Novo Nordisk's (NVO) first-quarter 2018 results beat earnings, but missed on revenue estimates.
This Small Biotech Is Building on a Surprising Success https://www.fool.com/investing/2018/04/24/this-small-biotech-is-building-on-a-surprising-suc.aspx?source=iedfolrf0000001 Apr 24, 2018 - Enanta Pharmaceuticals helped AbbVie score big last year. Now it's setting its sights even higher.
Novo Nordisk Obtains Licence for Sickle Cell Disease Program http://www.zacks.com/stock/news/298364/novo-nordisk-obtains-licence-for-sickle-cell-disease-program?cid=CS-ZC-FT-298364 Apr 06, 2018 - Novo Nordisk (NVO) secures a global licence for United States' biotech company EpiDestiny's sickle cell disease program EPI01.
Novo Nordisk A/S (NVO) Investor Presentation - Slideshow https://seekingalpha.com/article/4158935-novo-nordisk-s-nvo-investor-presentation-slideshow?source=feed_sector_healthcare Mar 26, 2018 - The following slide deck was published by Novo Nordisk A/S in conjunction with this event.
Novo Nordisk Poised on Strong Pipeline Amid Competition http://www.zacks.com/stock/news/296396/novo-nordisk-poised-on-strong-pipeline-amid-competition?cid=CS-ZC-FT-296396 Mar 21, 2018 - Novo Nordisk (NVO) has a strong product pipeline and their potential approval will boost sales of the company.
Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns http://www.zacks.com/stock/news/295726/diabetes-devices-market-on-a-tear-3-stocks-for-solid-returns?cid=CS-ZC-FT-295726 Mar 15, 2018 - Consider these three stocks in the rapidly-growing diabetes devices market for grand returns.

Pages: 1234567891011...17

<<<Page 6>